Review Note
Last Update: 02/20/2025 12:28 PM
Current Deck: **BU-MED Mother Deck Year 2 - 2nd Semester::PHARMACOLOGY::Urology Module::QBank
PublishedCurrently Published Content
Front
1. The effects of administration of an antimuscarinic agent to an individual with an overactive bladder (OAB) include all of the following EXCEPT:
a. increased total bladder capacity.
b. depressed amplitude of involuntary bladder contractions.
c. increased outlet resistance.
d. increased volume to the first involuntary bladder contraction.
e. increased mean volume voided.
a. increased total bladder capacity.
b. depressed amplitude of involuntary bladder contractions.
c. increased outlet resistance.
d. increased volume to the first involuntary bladder contraction.
e. increased mean volume voided.
Back
C.
c. Increased outlet resistance. Atropine and atropine-like agents will depress normal bladder contractions and involuntary bladder contractions of any cause. In such patients, the volume to the first involuntary bladder contraction will generally be increased, the amplitude of the involuntary bladder contraction decreased, and the total bladder capacity increased. Outlet resistance, at least as reflected by urethral pressure measurements, does not seem to be clinically affected
c. Increased outlet resistance. Atropine and atropine-like agents will depress normal bladder contractions and involuntary bladder contractions of any cause. In such patients, the volume to the first involuntary bladder contraction will generally be increased, the amplitude of the involuntary bladder contraction decreased, and the total bladder capacity increased. Outlet resistance, at least as reflected by urethral pressure measurements, does not seem to be clinically affected
No published tags.
Pending Suggestions
No pending suggestions for this note.